Filing Details
- Accession Number:
- 0001193125-19-153162
- Form Type:
- 13G Filing
- Publication Date:
- 2019-05-22 07:54:03
- Filed By:
- Karfunkel George
- Company:
- Oncocyte Corp (NYSE:OCX)
- Filing Date:
- 2019-05-22
- SEC Url:
- 13G Filing
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| George Karfunkel | 5,120,000 | 0 | 5,120,000 | 0 | 5,120,000 | 9.5% |
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. ___)
OncoCyte Corporation
(Name of Issuer)
Common Stock, no par value
(Title of Class of Securities)
68235C107
(CUSIP Number)
January 31, 2019
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
☐ Rule 13d - 1(b)
☒ Rule 13d - 1(c)
☐ Rule 13d - 1(d)
*The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
| CUSIP No. 68235C107 | 13G | Page 2 of 5 Pages |
| 1 | NAMES OF REPORTING PERSONS
George Karfunkel | |||||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐ (b) ☐ N/A | |||||
| 3 | SEC USE ONLY
| |||||
| 4 | CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America | |||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5 | SOLE VOTING POWER
5,120,000 | ||||
| 6 | SHARED VOTING POWER
0 | |||||
| 7 | SOLE DISPOSITIVE POWER
5,120,000 | |||||
| 8 | SHARED DISPOSITIVE POWER
0 |
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,120,000 | |||||
| 10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐
| |||||
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.5% | |||||
| 12 | TYPE OF REPORTING PERSON
IN | |||||
| CUSIP No. 68235C107 | 13G | Page 3 of 5 Pages |
| SCHEDULE 13G |
| Item 1(a). | Name of Issuer: OncoCyte Corporation | |
| Item 1(b). | Address of Issuers Principal Executive Offices: | |
| 1010 Atlantic Avenue, Suite 102 | ||
| Alameda, California 94501 | ||
| Item 2(a). | Name of Person Filing: George Karfunkel | |
| Item 2(b). | Address of Principal Business Office or, if None, Residence: | |
| 140 Broadway, 39th floor | ||
| New York, NY 10005 | ||
| Item 2(c). | Citizenship: United States of America | |
| Item 2(d). | Title of Class of Securities: Common stock, no par value | |
| Item 2(e). | CUSIP Number: 68235C107 | |
| Item 3. | If this statement is filed pursuant to Rule 13d-1(b) or Rule 13d-2(b) or (c), check whether the person filing is a: | |
| (a) | ☐ | Broker or dealer registered under Section 15 of the Act; | ||
| (b) | ☐ | Bank as defined in Section 3(a)(6) of the Act; | ||
| (c) | ☐ | Insurance company as defined in Section 3(a)(19) of the Act; | ||
| (d) | ☐ | Investment company registered under Section 8 of the Investment Company Act of 1940; | ||
| (e) | ☐ | An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); | ||
| (f) | ☐ | An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); | ||
| (g) | ☐ | A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); | ||
| (h) | ☐ | A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act; | ||
| (i) | ☐ | A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act; | ||
| (j) | ☐ | A non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J); | ||
| (k) | ☐ | Group, in accordance with Rule 13d-1(b)(1)(ii)(K). | ||
| If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please specify the type of institution: _______________ |
| CUSIP No. 68235C107 | 13G | Page 4 of 5 Pages |
| Item 4. | Ownership: |
| (a) | Amount beneficially owned: 5,120,000 | |
| (b) | Percent of class: 9.5% (Based upon publicly available information from Issuer). | |
| (c) | Number of shares as to which such person has: | |
| (i) | Sole power to vote or to direct the vote: | 5,120,000 | ||||
| (ii) | Shared power to vote or to direct the vote: | 0 | ||||
| (iii) | Sole power to dispose or to direct the disposition of: | 5,120,000 | ||||
| (iv) | Shared power to dispose or to direct the disposition of: | 0 | ||||
| Item 5. | Ownership of Five Percent or Less of a Class: If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☐. | |
| Item 6. | Ownership of More than Five Percent on Behalf of Another Person: Not Applicable | |
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person: Not Applicable. | |
| Item 8. | Identification and Classification of Members of the Group: Not Applicable. | |
| Item 9. | Notice of Dissolution of Group: Not Applicable. | |
| Item 10. | Certifications: |
| By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 14a-11. |
| CUSIP No. 68235C107 | 13G | Page 5 of 5 Pages |
| SIGNATURE |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
| Date: | May 21, 2019 | |
| By: | /s/ George Karfunkel | |
| Name: | George Karfunkel | |